<code id='2B87F3BBAC'></code><style id='2B87F3BBAC'></style>
    • <acronym id='2B87F3BBAC'></acronym>
      <center id='2B87F3BBAC'><center id='2B87F3BBAC'><tfoot id='2B87F3BBAC'></tfoot></center><abbr id='2B87F3BBAC'><dir id='2B87F3BBAC'><tfoot id='2B87F3BBAC'></tfoot><noframes id='2B87F3BBAC'>

    • <optgroup id='2B87F3BBAC'><strike id='2B87F3BBAC'><sup id='2B87F3BBAC'></sup></strike><code id='2B87F3BBAC'></code></optgroup>
        1. <b id='2B87F3BBAC'><label id='2B87F3BBAC'><select id='2B87F3BBAC'><dt id='2B87F3BBAC'><span id='2B87F3BBAC'></span></dt></select></label></b><u id='2B87F3BBAC'></u>
          <i id='2B87F3BBAC'><strike id='2B87F3BBAC'><tt id='2B87F3BBAC'><pre id='2B87F3BBAC'></pre></tt></strike></i>

          knowledge

          knowledge

          author:entertainment    Page View:8

          On this week’s “Readout LOUD,” we’re live in San Francisco at STAT’s Breakthrough Summit West. AI is a big theme this year, everywhere, so on that note, we chat with our AI correspondent — and recent Pulitzer finalist — Casey Ross, who sat down on stage to discuss AI-centered drug discovery with both NVIDIA and Google-backed Isomorphic Labs.

          We also discuss this week’s biotech news, including yet more obesity drug data, this time from Roche, and the closing of Novartis’ acquisition of MorphoSys.

          advertisement

          Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

          And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

          explore

          23andMe had bad news about my health. I wish a person had delivered it
          23andMe had bad news about my health. I wish a person had delivered it

          ERICBARADAT/AFP/GettyImagesLastsummer,IthoughtitmightbefuntohavemyDNAanalyzed.Twocompanies,23andMean

          read more
          ReNAgade cuts staff seven months after raising $300 million
          ReNAgade cuts staff seven months after raising $300 million

          AdobeBiotechstartupReNAgadeTherapeuticsiscuttingstaffjustsevenmonthsafterraisingthelargestSeriesArou

          read more
          Jerome Adams on the need for new antivirals for Covid
          Jerome Adams on the need for new antivirals for Covid

          PaxlovidtabletsamplesbeinginspectedinFreiburg,Germany.PfizerviaAPTheU.S.Covid-19Public HealthEmergen

          read more

          FDA panel endorses Alnylam’s heart drug — after picking it apart

          KristofferTripplaar/SipaUSA/APAgroupofadviserstotheFoodandDrugAdministrationvotedinfavorofAlnylamPha